Loading...
XJPX
4530
Market cap2.62bUSD
May 08, Last price  
6,040.00JPY
Name

Hisamitsu Pharmaceutical Co Inc

Chart & Performance

D1W1MN
XJPX:4530 chart
P/E
22.19
P/S
2.61
EPS
272.17
Div Yield, %
1.71%
Shrs. gr., 5y
-2.55%
Rev. gr., 5y
6.29%
Revenues
163.02b
+4.50%
137,184,000,000137,794,000,000137,794,000,000142,772,000,000150,635,000,000156,743,000,000161,852,000,000161,852,000,000145,925,000,000147,870,000,000143,408,000,000140,992,000,000140,992,000,000114,510,000,000120,193,000,000128,330,000,000141,706,000,000141,706,000,000156,006,000,000163,024,000,000
Net income
19.16b
-11.94%
20,956,000,00018,439,000,00018,439,000,00018,809,000,00021,357,000,00018,784,000,00017,784,000,00017,784,000,00020,395,000,00019,119,000,00019,204,000,00018,694,000,00018,694,000,0009,250,000,0009,658,000,00011,742,000,00013,969,000,00013,969,000,00021,758,000,00019,161,000,000
CFO
17.48b
-6.86%
36,342,000,00025,558,000,00025,558,000,00032,485,000,00035,845,000,00023,232,000,00030,923,000,00030,923,000,00019,910,000,00030,453,000,00015,772,000,00027,395,000,00027,395,000,0005,289,000,00019,199,000,00012,727,000,00018,188,000,00018,188,000,00018,765,000,00017,478,000,000
Dividend
Feb 26, 202660 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Hisamitsu Pharmaceutical Co., Inc. is a company dedicated to the entire lifecycle of healthcare products, from initial research and development to manufacturing and global distribution of pharmaceuticals and related health solutions. It is particularly recognized for its well-known brands such as Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat. Beyond these, Hisamitsu's diverse portfolio encompasses prescription-only medicines, over-the-counter remedies, medical devices, nutritional supplements, and a range of topical products designed for pain relief. Established by Nihei Hisamitsu in 1847, the company maintains its corporate headquarters in Tosu, Japan.
URL
https://www.hisamitsu.co.jp/
IPO date
Sep 01, 1962
Employees
2,769
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2026‑022025‑022024‑022024‑022023‑022022‑022021‑022020‑022020‑022019‑022018‑022017‑02
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT